Search research articles
Contact Us
Filters
Showing results (131-140 of 173) with videos related to
Page
of 18
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2020
The anti-fibrotic actions of relaxin are mediated through AT<sub>2</sub> R-associated protein phosphatases via RXFP1-AT<sub>2</sub> R functional crosstalk in human cardiac myofibroblasts
Chao Wang, Anita A Pinar, Robert E Widdop, et al.
Canadian Respiratory Journal
|
January 30, 2023
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis
Udari Eshani Perera, Louise Organ, Simon G Royce, et al.
Journal of Biomedical Science
|
December 11, 2025
Immune cell uptake of glycinated nanoparticles conjugated to anti-fibrotic peptides enables their prolonged activity and oral administration
Deidree V N Somanader-Livera, Chen Wei, Chao Wang, et al.
Chemico-Biological Interactions
|
May 18, 2024
Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles
Gabriele De Rubis, Amlan Chakraborty, Keshav Raj Paudel, et al.
British Journal of Pharmacology
|
January 15, 2021
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension
Yifang Li, Matthew Shen, Dorota Ferens, et al.
ACS Pharmacology & Translational Science
|
April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil
Yan Wang, Lei Han, Matthew Shen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 12, 2011
Relaxin remodels fibrotic healing following myocardial infarction
Chrishan S Samuel, Sofia Cendrawan, Xiao-Ming Gao, et al.
Physiological Reports
|
August 1, 2014
Low-dose maternal alcohol consumption: effects in the hearts of offspring in early life and adulthood
Vivian B Nguyen, Megan E Probyn, Fiona Campbell, et al.
Endocrinology
|
November 10, 2007
Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis
Qi Xu, Edna D Lekgabe, Xiao-Ming Gao, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy
Eleni Giannakis, Chrishan S Samuel, Tim D Hewitson, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 173) with videos related to
Sort By:
Page
of 18
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2020
The anti-fibrotic actions of relaxin are mediated through AT<sub>2</sub> R-associated protein phosphatases via RXFP1-AT<sub>2</sub> R functional crosstalk in human cardiac myofibroblasts
Chao Wang, Anita A Pinar, Robert E Widdop, et al.
Canadian Respiratory Journal
|
January 30, 2023
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis
Udari Eshani Perera, Louise Organ, Simon G Royce, et al.
Journal of Biomedical Science
|
December 11, 2025
Immune cell uptake of glycinated nanoparticles conjugated to anti-fibrotic peptides enables their prolonged activity and oral administration
Deidree V N Somanader-Livera, Chen Wei, Chao Wang, et al.
Chemico-Biological Interactions
|
May 18, 2024
Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles
Gabriele De Rubis, Amlan Chakraborty, Keshav Raj Paudel, et al.
British Journal of Pharmacology
|
January 15, 2021
Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension
Yifang Li, Matthew Shen, Dorota Ferens, et al.
ACS Pharmacology & Translational Science
|
April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil
Yan Wang, Lei Han, Matthew Shen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 12, 2011
Relaxin remodels fibrotic healing following myocardial infarction
Chrishan S Samuel, Sofia Cendrawan, Xiao-Ming Gao, et al.
Physiological Reports
|
August 1, 2014
Low-dose maternal alcohol consumption: effects in the hearts of offspring in early life and adulthood
Vivian B Nguyen, Megan E Probyn, Fiona Campbell, et al.
Endocrinology
|
November 10, 2007
Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis
Qi Xu, Edna D Lekgabe, Xiao-Ming Gao, et al.
Proteomics. Clinical Applications
|
December 8, 2010
Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy
Eleni Giannakis, Chrishan S Samuel, Tim D Hewitson, et al.
Page
of 18